"Our primary care locations are open, safe and available for appointments including flu shot appointments for this 2020-2021 season. New safety measures are in place for your protection. To make an in-person and virtual telemedicine appointments, schedule online through eCare or call the clinic directly. If you have any of the following new symptoms contact us first before coming into a primary care or urgent care clinic: chills, cough, fever, gastrointestinal issues (nausea, vomiting, diarrhea), headache, loss of taste or smell, muscle pain, runny nose, shortness of breath, or sore throat."

During the past decade, Univ of Washington / Madison Clinic conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Univ of Washington / Madison Clinic" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 5 trials, followed by "AIDS Malignancy Consortium" with 2 trials sponsored, "Biocodex" with 1 trials sponsored, "Toltec Pharmaceuticals, LLC" with 1 trials sponsored and "University of Washington" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Univ of Washington / Madison Clinic" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Oclassen Pharmaceuticals" with 2 trials as a collaborator, "The Emmes Company, LLC" with 2 trials as a collaborator, "University of Arkansas" with 2 trials as a collaborator and "AIDS and Cancer Specimen Resource" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Univ of Washington / Madison Clinic" are "HIV Infections" (4 trials), "Cytomegalovirus Infections" (2 trials), "Anal Chlamydia Infection" (1 trials), "Bacterial Vaginosis" (1 trials) and "Cervical Cancer" (1 trials). Many other conditions were trialed in "Univ of Washington / Madison Clinic" in a lesser frequency.

Most popular intervention types in "Univ of Washington / Madison Clinic" are "Drug" (7 trials), "Other" (3 trials), "Device" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Acyclovir" (1 trials), "Azithromycin" (1 trials), "Benzathine Penicillin" (1 trials), "DNA analysis" (1 trials) and "Doxycycline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Univ of Washington / Madison Clinic" are 7 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Univ of Washington / Madison Clinic". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in Univ of Washington / Madison Clinic, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Univ of Washington / Madison Clinic, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".